Greek pharma industry scales up investment in R&D and production

The Greek pharmaceutical sector is increasing investment in research, technology, and production capacity. The scale and specific projects are not detailed, but the move signals a strategic expansion of domestic manufacturing and innovation. This is a sector-specific corporate development with limited immediate macro-market impact.